Atara Biotherapeutics, Inc. Annual Operating Income (Loss) in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
  • Atara Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$12.2M, a 79.6% increase year-over-year.
  • Atara Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$83.4M, a 69.8% increase year-over-year.
  • Atara Biotherapeutics, Inc. annual Operating Income (Loss) for 2024 was -$83.4M, a 69.8% increase from 2023.
  • Atara Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$276M, a 1.61% increase from 2022.
  • Atara Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$281M, a 17.6% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$83.4M +$193M +69.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 -$276M +$4.51M +1.61% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
2022 -$281M +$59.9M +17.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$340M -$31.4M -10.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-08
2020 -$309M -$13.4M -4.52% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-08
2019 -$296M -$58.6M -24.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$237M -$116M -95.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$122M -$40.3M -49.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$81.2M -$22.8M -39% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$58.4M -$30.3M -108% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 -$28.2M -$19.5M -227% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 -$8.62M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.